skip to Main Content
NEWS
[Edaily] C&R Research Achieves 55.1 Billion KRW In Revenue Last Year… Up By 13.7% Year-on-Year

[Edaily] C&R Research achieves 55.1 Billion KRW in Revenue Last Year… Up by 13.7% Year-on-Year

C&R Research (359090) announced its provisional performance, reporting a 13.7% increase in revenue and a 41.6% increase in net profit…

Read more →
[Hankyung] C&R Research And Sungkyunkwan University’s College Of Pharmacy Signed A Clinical Trial Platform Development Agreement

[Hankyung] C&R Research and Sungkyunkwan University’s College of Pharmacy signed a clinical trial platform development agreement

C&R Research announced on the 29th Jan that it has signed a joint research agreement with the College of Pharmacy at…

Read more →
[Medipana] C&R Research Accelerates Global Expansion In The Era Of 100 Billion KRW Contract Orders

[Medipana] C&R Research accelerates Global Expansion in the Era of 100 Billion KRW Contract Orders

C&R Research, a contract research organization (CRO) led by CEO Moon-Tae Yoon, has embarked on global market expansion with the…

Read more →
[Hankyung] Top 1 CRO, C&R Research Announced To Increase The Global Revenue Share To 30% Within 6 Years

[Hankyung] Top 1 CRO, C&R Research announced to increase the global revenue share to 30% within 6 years

"At the end of last year, we established overseas subsidiaries in the United States and Thailand. We aim to increase…

Read more →
[Pharmnews] C&R Research Received The ‘Innovative CRO’ Certification From Korea National Enterprise For Clinical Trials (KoNECT)

[Pharmnews] C&R Research received the ‘Innovative CRO’ certification from Korea National Enterprise for Clinical Trials (KoNECT)

C&R Research received the 'Innovative CRO' certification with the highest score ever in the professional areas of 'Project Management' and…

Read more →
Back To Top